Yahoo
Tokyo - Delayed Quote JPY

CellSeed Inc. (7776.T)

185.00 -3.00 (-1.60%)
As of 11:23:01 AM GMT+9. Market Open.
Chart Range Bar
Loading chart for 7776.T
  • Previous Close 188.00
  • Open 187.00
  • Bid 185.00 x --
  • Ask 185.00 x --
  • Day's Range 183.00 - 187.00
  • 52 Week Range 175.00 - 444.00
  • Volume 108,200
  • Avg. Volume 167,523
  • Market Cap (intraday) 7.293B
  • Beta (5Y Monthly) 1.21
  • PE Ratio (TTM) --
  • EPS (TTM) -28.97
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

CellSeed Inc. engages in the cell sheet regenerative medicine business in Japan, the rest of Asia, and Europe. It operates through Regenerative Medicine Support Business and Cell Sheet Regenerative Medicine Business segments. The company is involved in commercializing regenerative medicine using cell sheets, which include autologous and allogeneic chondrocyte sheets. It also offers regenerative medicine contract services comprising contract development and manufacturing; contract manufacturing and consulting for specified cell-based products; and training and education in cell culturing technology services. In addition, the company provides UpCell, a temperature-responsive cell cultureware for cell sheet engineering; RepCell, a temperature-responsive cell cultureware for cell collection; HydroCell, a low cell binding cultureware; ThermoPlate III, a heating element made of a transparent glass plate; cellZscope, an automated cell monitoring system; and cell sheet support products. CellSeed Inc. was incorporated in 2001 and is headquartered in Koto, Japan.

www.cellseed.com

44

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

7776.T
28.57%
Nikkei 225 (^N225)
25.35%

1-Year Return

7776.T
57.57%
Nikkei 225 (^N225)
20.40%

3-Year Return

7776.T
41.46%
Nikkei 225 (^N225)
97.51%

5-Year Return

7776.T
19.21%
Nikkei 225 (^N225)
113.76%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 13M
Earnings -272M
Profit Margin -2,092.31%

Q3

FY24

Q1

FY25

Q3

FY25

Q1

FY26

-300M
-200M
-100M
0
-2000.0%
-1500.0%
-1000.0%
-500.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -33.81%

  • Return on Equity (ttm)

    -71.66%

  • Revenue (ttm)

    161M

  • Net Income Avi to Common (ttm)

    -914M

  • Diluted EPS (ttm)

    -28.97

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    930M

  • Total Debt/Equity (mrq)

    15.50%

  • Levered Free Cash Flow (ttm)

    -580.63M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: